NZMS and AMSL Acquisition

2024 has started with a bang here at InterMed!

We are excited to announce a significant milestone in our journey – the successful acquisition of the Medical, Scientific, and Regenerative Medicine divisions of Australasian Medical & Scientific Ltd (AMSL) and New Zealand Medical & Scientific Ltd (NZMS).

Effective 1st February, the acquisition of these businesses marks a transformative opportunity for InterMed. Not only will it strengthen our presence in the Medical market but also extend our reach into the new and exciting areas of Regenerative Medicine and Scientific solutions, representing a major step towards diversifying our product portfolio and expanding our reach in Australia and New Zealand. Our team, along with AMSL and NZMS, have worked tirelessly to transition these businesses, fueled by our unwavering commitment to delivering uninterrupted service to our valued supplier partners and customers alike.

We want to warmly welcome those from AMSL and NZMS who have joined us on this journey and will be an integral part of the InterMed team. The acquisition brings immense possibilities, and we look forward to continued success in Australia and New Zealand.